To further explore the role of interleukin-2 (IL-2) in cardiac function, we investigated its effects on the intracellular calcium transient and the activity of sarcoplasmic reticulum (SR) Ca 2ϩ -ATPase in rat cardiomyocytes. IL-2 (200 U/ml) decreased the amplitude of electrically stimulated and caffeine-induced intracellular Ca 2ϩ transients in ventricular myocytes, but increased the end-diastolic calcium level. IL-2 did not affect the sarcolemmal L-type Ca 2ϩ channel activity. The activity of SR Ca 2ϩ -ATPase from IL-2-treated hearts increased in a dose-dependent manner, but the sarcolemmal Ca 2ϩ -ATPase activity did not change. After incubation of SR with ATP, the activity of SR Ca 2ϩ -ATPase from IL-2-treated hearts increased much more than that in the control group. The responsiveness of SR Ca 2ϩ -
ATPase from IL-2-perfused hearts to the free calcium concentration was inhibited. The Ca 2ϩ uptake and Ca 2ϩ content were reduced in the SR vesicles prepared from IL-2-treated rat heart. Pretreatment with the -opioid receptor antagonist nor-binaltorphimine (10 nM) attenuated the effect of IL-2 on the SR Ca 2ϩ -ATPase activity, SR Ca 2ϩ uptake, and Ca 2ϩ content. The activity of Ca 2ϩ -ATPase in SR isolated from untreated hearts did not change when IL-2 and SR were coincubated. Thus, we conclude that the decreased calcium transient induced by IL-2 results from reduced SR calcium release, which is due to decreased SR Ca 2ϩ uptake mediated by cardiac -opioid receptors, but not from reduced activity of the sarcolemmal L-type calcium channel.
Current evidence suggests that the process of contraction in heart muscle is mainly initiated by the action potential activating L-type channels to cause an influx of Ca 2ϩ . The voltage-dependent Ca 2ϩ influx induces Ca 2ϩ release across the sarcoplasmic reticulum (SR) by a process known as Ca 2ϩ -induced Ca 2ϩ release (Fabiato, 1983) . Together, both sources of Ca 2ϩ initiate contraction (Sipido and Wier, 1991; Barry and Bridge, 1993) . Relaxation takes place as a result of two main systems that act to decrease the cytoplasmic Ca 2ϩ concentration. The SR Ca 2ϩ -ATPase pumps Ca 2ϩ back into the SR ready for release at the next beat, and the sarcolemmal Na ϩ /Ca 2ϩ exchanger extrudes the Ca 2ϩ that entered the cell. Although other mechanisms (the sarcolemmal Ca 2ϩ -ATPase and the mitochondria) are involved in the maintenance of a low cytoplasmic Ca 2ϩ concentration, the proteins that perform the major roles on a beat-to-beat basis are the SR Ca 2ϩ -ATPase and the Na ϩ /Ca 2ϩ exchanger (Bers, 2000) .
The Ca 2ϩ -ATPase of the SR catalyzes the most important step in relaxation by coupling cleavage of ATP to transport of two Ca 2ϩ into the SR lumen (Ikemoto, 1982; Inesi, 1985) . This process comprises an ordered sequence of elementary events consisting of phosphorylation and dephosphorylation reactions of the enzyme as well as a conformational oscillation that exposes its Ca 2ϩ binding moiety either at the cytoplasmic or the luminal side. A dysfunction of SR Ca 2ϩ -ATPase has been proposed as a contributing factor to the development of cardiovascular diseases in which cytokines are involved, such as genetic hypertension (Nomura et al., 1997) , ischemia and reperfusion injury, myocardial stunning, and heart failure (Zucchi and Ronca-Testoni, 1997) .
Interleukin-2 (IL-2), one of the important cytokines, is generally produced by activated helper T lymphocytes and stimulates proliferation and effector functions in various cells of the immune system. IL-2 is also known to have cardiac effects. A negative inotropic effect of IL-2 has been reported in hamster papillary muscles (Finkel et al., 1992) and isolated ventricular myocytes (Cao et al., 2002) . Associated with the change in contractility profile are alterations in intracellular calcium regulation. In IL-2-treated cardiomyocytes, Ca 2ϩ regulation is altered, manifesting as a smaller cytoplasmic Ca 2ϩ transient and elevated end-diastolic calcium level (Cao et al., 2002) . However, very little information is available on IL-2-induced changes in calcium handling. It is known that a decreased intracellular calcium transient might be accounted for by reduced influx of extracellular calcium and/or reduced calcium release from SR as a result of low calcium content. Furthermore, the increased end-diastolic calcium level might result from reduced calcium reuptake by SR Ca 2ϩ -ATPase or decreased calcium extrusion through the sarcolemmal Na ϩ /Ca 2ϩ exchanger. It has been demonstrated that the negative inotropic effect and decreased calcium transient induced by IL-2 are mediated by the cardiac sarcolemmal -opioid receptor (Cao et al., 2002) . So, the opioid receptor may be involved in changes of calcium handling induced by IL-2. Therefore, we hypothesized that the alterations of intracellular calcium handling in active and resting cardiomyocytes during IL-2 challenge may result from abnormalities of SR Ca 2ϩ -ATPase activity by activating the sarcolemmal -opioid receptor.
Therefore, the aim of the present study was to investigate whether IL-2 alters SR Ca 2ϩ -ATPase activity and/or the properties of the contractile apparatus in rat hearts and, if so, by which possible mechanisms. In particular, the activity of SR Ca 2ϩ -ATPase was examined with special emphasis on the -opioid receptor-mediated pathways.
Materials and Methods
All procedures used in this study were approved by the Ethics Committee for the Use of Experimental Animals in Zhejiang University.
Preparation of Isolated Ventricular Myocytes
Ventricular myocytes from adult male Sprague-Dawley rats (250.21 Ϯ 10.56 g) were isolated by enzymatic dissociation (Farmer et al., 1983) . The hearts were excised, cannulated via the aorta, attached to a Langendorff apparatus, and perfused with a 100% oxygenated, nonrecirculating, Ca 2ϩ -free Tyrode's solution (pH 7.2) containing 100 mmol/l NaCl, 10 mmol/l KCl, 1.2 mmol/l KH 2 PO 4 , 5 mmol/l MgSO 4 , 20 mmol/l glucose, and 10 mmol/l 3-(N-morpholino)propanesulfonic acid (MOPS). Then the perfusion solution was switched to a 100% oxygenated recirculated low-Ca 2ϩ (50 M) Tyrode's solution containing 0.03% collagenase and 1% bovine serum albumin (BSA) for 10 min. The ventricles were cut, minced, and gently triturated with a pipette in the low-Ca 2ϩ Tyrode's solution containing BSA at 37°C for 10 min. The cells were filtered through 200-m nylon mesh and resuspended in the Tyrode's solution in which the Ca 2ϩ concentration was gradually increased to 1.25 mM over 40 min. Only rod-shaped cells with clear cross-striations were used for experiments.
Intracellular Calcium Recording
Intracellular calcium was monitored using the fluorescent dye fura-2/acetoxymethyl ester (AM). The acetoxymethyl ester form of fura-2 was added to a suspension of cells. After incubation with 1 M fura-2/AM at room temperature for 30 min, the cells were washed three times with fresh Krebs-Henseleit (K-H) solution containing 1% BSA. K-H solution contained 118 mmol/l NaCl, 4.7 mmol/l KCl, 1.2 mmol/l KH 2 PO 4 , 1.2 mmol/l MgSO 4 , 25 mmol/l NaHCO 3 , 1.25 mmol/l CaCl 2 , and 10 mmol/l glucose. Fluorescence was measured on an inverted microscope (Olympus, Tokyo, Japan) equipped with a fluorometer system (T.I.L.L., Photonics GmbH, Grafelfing, Germany). A small aliquot of fura-2-loaded cells was placed on the glass bottom of a chamber and then perfused with K-H buffer with a gas phase of 95% O 2 , 5% CO 2 . The Ca 2ϩ -dependent fura-2 signal was obtained by illuminating at 340 and 380 nm and recording the emitted light at 510 nm. The background fluorescence was automatically subtracted. As in previous studies in other laboratories (Ventura et al., 1992; Kotsanas et al., 2000) , we used the fluorescence ratio at the two wavelengths, which is believed to accurately represent the [Ca 2ϩ ] i . The [Ca 2ϩ ] i transient was induced by suprathreshold stimulation at 0.2 Hz delivered through two platinum field-stimulation electrodes in the bathing fluid.
Measurement of Sarcolemmal Ca
2؉ Channel Activity Using Mn 2؉ Influx Mn 2ϩ quench experiments were performed in Ca 2ϩ medium containing 0.2 mM MnCl 2 by continuously recording the excitation signals at 360 nm and the emission signal at 510 nm at 1-ms intervals (Merritt et al., 1989) . Freshly isolated, quiescent cardiomyocytes preloaded with fura-2/AM were perfused continuously with an incubation buffer at a flow rate of 5 ml/min at room temperature. Incubation buffer (pH 7.4) contained 130 mmol/l NaCl, 4.7 mmol/l KCl, 0.1 mmol/l KH 2 PO 4 , 1.2 mmol/l MgSO 4 , 0.1 mmol/l CaCl 2 , 10 mmol/l HEPES, and 10 mmol/l glucose. After 12 min perfusion with continuous electrical stimulation, the perfusion was switched to buffer supplemented with 0.2 mM MnCl 2 and the electrical stimulation was stopped. After 75 s, during which the basal quench was determined, electrical stimulation (1 Hz) was initiated to activate Mn 2ϩ quench of fura-2 via voltage-sensitive Ca 2ϩ channels. Drugs were added 12 min before the initiation of Mn 2ϩ quench acquisition, except for isoproterenol, which was added 85 s before the Mn 2ϩ perfusion was initiated. Ca 2ϩ channel activity was monitored as the rate of fura-2 quench that was activated by electrical pacing of the cardiomyocytes and could be blocked by nifedipine.
Whole Cell L-Type Calcium Current Measurements
Myocytes were placed in a superfusion chamber and superfused at 2 ml/min, using a physiological solution of the following composition: 135 mmol/l NaCl, 5 mmol/l CsCl, 1 mmol/l MgCl 2 , 1.5 mmol/l CaCl 2 , 10 mmol/l HEPES, and 10 mmol/l glucose, pH 7.4. Myocytes were then patch clamped in the whole cell configuration, using a patch pipette (resistance ϳ2-2.5 M⍀) filled with the following solution: 135 mmol/l CsCl, 3 mmol/l MgCl 2 , 10 mmol/l HEPES, 10 mmol/l EGTA, 0.5 mmol/l cAMP, and 2 mmol/l MgATP, pH 7.3. Calcium current recordings were measured using Axopatch 200B amplifier/pClamp7 software (Axon Instruments, Inc., Foster City, CA). Fast sodium currents were eliminated using a prepulse to Ϫ40 mV for 40 ms before the test pulse.
Isolated Perfused Rat Heart Preparation
Male Sprague-Dawley rats were used. Immediately after stunning and decapitation, the heart was rapidly removed and mounted to a Langendorff apparatus. The heart was retrogradely perfused with a 95% O 2 , 5% CO 2 equilibrated K-H solution via the aorta at a constant velocity of 10 ml/min. The heart was allowed to stabilize for 10 min before the experiment commenced. The heart was perfused for 10 min with IL-2 at 10, 40, 200, or 800 U/ml, and then was quickly removed from the apparatus after each experiment, frozen in liquid nitrogen, and stored at Ϫ80°C.
Preparation of SR from Rat Heart
Sarcoplasmic reticulum was prepared according to the methods of Jones as modified by Kodavanti et al. (Jones, 1979; Kodavanti et al., 1990; Pande et al., 1998) . The whole hearts were transferred to ice-cold homogenizing medium containing 50 mmol/l Na 2 HPO 4 , 10 mmol/l Na 2 EDTA, and 25 mmol/l NaF, pH 7.4. The ventricles were minced and placed in 10 ml of ice-cold homogenizing medium. The minced tissue was homogenized in three bursts of 15 s each. An additional 5 ml of homogenizing medium was added and the homogenate was sedimented twice for 20 min at 14,000g. The supernatant was recentrifuged at 45,000g for 30 min. The pellet obtained after Interleukin-2 and Calcium Handling in Rat Heart 573 this centrifugation, consisting of crude membrane vesicles (SR), was suspended in storage buffer (30 mM histidine, 0.25 mol/l sucrose, 10 mM EDTA, and 10 mM NaF, pH 7.4) to a final concentration of 30 to 40 mg/ml protein and stored at Ϫ80°C until used.
Cardiac SR fractions were used for measurement of the activity of SR Ca 2ϩ -ATPase. All experiments were carried out in triplicate. Each sample contained pooled ventricular tissue from five hearts.
Preparation of Sarcolemma from Rat Heart
Sarcolemma was prepared from rat ventricles by the methods of Watanabe et al. (1998) and Woo et al. (2001) . The ventricles were minced in 10 ml of 0.6 mol/l sucrose in 10 mM imidazole-HCl buffer, pH 7.0, and homogenized on ice for 30 s. The homogenate was centrifuged at 12,000g for 30 min at 4°C. The supernatant was diluted with 120 ml KCl/MOPS buffer (0.16 mol/l KCl and 20 mM MOPS, pH 7.4) and centrifuged at 96,000g for 1 h at 4°C. The pellet was resuspended in 30% sucrose in 0.1 mol/l Tris-HCl, pH 8.3, containing 0.3 mol/l KCl and 50 mM sodium pyrophosphate. KCl/ MOPS buffer was layered on top of this suspension in an ultracentrifuge tube. The tube was centrifuged at 96,000g for 1 h at 4°C. The white band at the interface between the KCl/MOPS and the 30% sucrose was recovered and diluted with 3 volumes of KCl/MOPS buffer and then centrifuged at 96,000g for 30 min at 4°C. The pellet was resuspended in 1.5 ml of 0.25 mol/l sucrose in 30 mM imidazoleHCl, pH 7.4. The isolated sarcolemma, 40 to 50 mg/ml, was frozen in aliquots in liquid nitrogen and stored at Ϫ80°C.
Protein Determination
Protein content of the sarcoplasmic reticulum and membrane was determined by the method of Lowry et al. (1951) with BSA as the standard.
Measurement of Ca 2؉ -ATPase Activity
The activity of Ca 2ϩ -ATPase was determined with a kit (Jiancheng Co., Nanjing, China) by measuring the inorganic phosphate (Pi) liberated from ATP hydrolysis (Kodavanti et al., 1990) . Ca 2ϩ -ATPase activity was assayed in a medium containing 50 mM histidine, pH 7.0, 3 mM MgCl 2 , 100 mM KCl, 5 mM sodium azide, 3 mM ATP, and 50 M CaCl 2 (Pande et al., 1998) . Cardiac SR membranes were added to the reaction mixture at a final concentration of 20 to 25 g of protein per milliliter, preincubated for 10 min at 37°C and the reaction was initiated by the addition of ATP. The ATP hydrolysis that occurred in the absence of Ca 2ϩ (1 mM EGTA) was subtracted to determine the activity of Ca 2ϩ -stimulated ATPase. Ouabain was added fresh to a final concentration of 1 mM in the media, which remained unchanged throughout the incubation. Mitochondrial contamination was assessed by determining the activity of azide-sensitive ATPase, i.e., that activity inhibited by 5 mM sodium azide (Lindemann et al., 1983) . The Ca 2ϩ -ATPase activity of ϳ7 to 9 mol of Pi/mg protein/h reported in this study is very close to previous published values (Pande et al., 1998) . The lower activity value may be due to the fact that we used a crude SR preparation compared with semipurified fractions reported by others. 
Measurement of SR Ca 2؉ Uptake
Fura-2 free acid was used to continuously monitor the ATP-dependent Ca 2ϩ uptake according to the method described previously (Kargacin and Kargacin, 1994) . Freshly prepared cardiac SR vesicles were used for uptake studies immediately after resuspension in assay buffer (100 mmol/l KCl, 10 mmol/l oxalate, 5 mmol/l MgCl 2 , 25 mmol/l HEPES, and 0.05 mmol/l EGTA, pH 7.0). Reactions were performed in a final volume of 2 ml with 250 g of vesicle preparation, 5 mM ATP, and an initial [Ca 2ϩ ] of 1.5 M as assessed by the fluorescence ratio from fura-2 (10 M). Uptake reactions were initiated by the addition of Ca 2ϩ to a cuvette containing the SR vesicles. The solution in the cuvette was constantly stirred to insure adequate mixing. The fluorescence ratio due to excitation at 340 and 380 nm was measured at 510-nm emission using a fluorescence spectrophotometer (RF-1501; Shimadzu, Kyoto, Japan). To inhibit the Ca 2ϩ release through ryanodine receptors on SR, the experimental medium was supplemented with 10 M ruthenium red. All experiments were done at room temperature. Single exponential decays were fitted to the [Ca 2ϩ ] records using Clampfit 8.0 (Axon Instruments, Inc.).
Determination of Ca 2؉ Content in Preparations of SR Vesicles
Samples of SR vesicles were digested with 2 ml of 1 N H 2 NO 3 for 24 h. The digestant was crystal clear. Using a distilled water/0.1% lanthanum chloride-containing diluent, the digestant was diluted 1:50. This was to prevent chemical interference from phosphate ions. Absorbance of aliquots of the extracts was measured by atomic absorption using a flame photometer (180-50; Hitachi, Yokohama, Japan) in the following conditions: range UV (i.e., 422.7 nm), slit 2.6 nm, fuel-air-acetylene-oxidizing flame. An external calibration curve was constructed using an aqueous solution of CaCl 2 .
Assay of cAMP
After treatment, the hearts were immediately removed from the Langendorff apparatus and placed in liquid nitrogen. Then, these preparations were preserved at Ϫ80°C until use. About 250 mg of myocardium was obtained from the ventricles. The myocardium was homogenized in buffer containing 4 mM EDTA (to prevent enzymatic degradation of cAMP), followed by heating for several minutes in a boiling water bath to coagulate the protein. The extracts were centrifuged at 12,000 rpm for 15 min. The cAMP in the supernatant was assayed following the indications of the manufacturer (Chinese Academy of Atomic Sciences, Beijing, China). Protocol 5: Effect of IL-2 on the Activity of SR Ca 2؉ -ATPase of Rat Heart Pretreated with nor-BNI. To investigate whether exposure to IL-2 causes changes in SR Ca 2ϩ -ATPase activity via the opioid receptor pathway, the effect of IL-2 on SR Ca 2ϩ -ATPase of rat hearts pretreated with an opioid receptor antagonist was examined. The isolated rat hearts were perfused with the specific -opioid receptor antagonist nor-BNI (10 nM) for 10 min (Wu et al., 1999) , and then IL-2 (200 U/ml) was added to the perfusion buffer for 10 min.
Experimental Protocols
Protocol 6: Effect of IL-2 on SR Ca 2؉ Uptake and Ca
2؉
Content. To verify the output of the SR Ca 2ϩ -ATPase activation, the effect of IL-2 on SR Ca 2ϩ uptake and SR Ca 2ϩ content was determined. The rat hearts were exposed to IL-2 at 200 U/ml for 10 min with or without pretreatment of nor-BNI (10 nM) for 10 min, and then harvested for preparation of SR.
Chemicals
Collagenase (type I), BSA, MOPS, taurine, fura-2/AM, fura-2 free acid, ruthenium red, isoproterenol, nifedipine, tetraethylammonium, thapsigargin, nor-BNI, MgATP, cAMP, and ATP were purchased from Sigma-Aldrich (St. Louis, MO). IL-2 was purchased from Shanghai Huaxin High Biotechnology Inc. (Shanghai, China). The cAMP kit was provided by the Chinese Academy of Atomic Sciences. A stock solution (100,000 U/ml) of IL-2 was prepared in distilled water. Different aliquots (ϳ1-10 l) of the test solution were added to the reaction mixture to obtain the desired final concentrations of 10, 40, 200, and 800 U/ml.
Statistical Analysis
Values presented here are means Ϯ S.D. Statistical comparisons were performed by Student's t test, except for the dose-response data, which were analyzed by one-way analysis of variance and Dunnett's test. Differences of p Ͻ 0.05 are regarded as significant.
Results
Effect of IL-2 on Intracellular Calcium Transients Induced by Electrical Field Stimulation and Caffeine. Perfusion with 200 U/ml IL-2 significantly reduced the amplitude of the electrically stimulated [Ca 2ϩ ] i transient, which indicates the release of Ca 2ϩ during excitation-contraction coupling (Yew et al., 1998) . The basal fluorescence ratio of fura-2-loaded myocytes, an indication of the end-diastolic Ca 2ϩ level during excitation-contraction coupling (Yew et al., 1998) , was significantly increased in IL-2-treated isolated myocytes (Fig. 1) .
The decay of the electrically induced [Ca 2ϩ ] i transients was measured to determine the uptake of Ca 2ϩ by SR. The rate of the decay in the electrically induced [Ca 2ϩ ] i transient of myocytes as indicated by the time constant of transient decay, tau () (Trafford et al., 2001) , was prolonged 28.02% in IL-2-treated myocytes over that in control myocytes (Fig. 1) .
We evaluated the effect of IL-2 on the Ca 2ϩ stored in the Effect of IL-2 on Sarcolemmal L-Type Calcium Channel Activity. To investigate whether the decrease in the [Ca 2ϩ ] i transient induced by IL-2 was through the sarcolemmal Ca 2ϩ channel, we used the whole cell patch-clamp technique to test the effect of IL-2 on the calcium current. In 16 cells, perfusion with 200 U/ml IL-2 for 10 min had no significant effect on the whole cell L-type calcium current (Fig. 3) .
We used Mn 2ϩ as a Ca 2ϩ surrogate to pass through the Ca 2ϩ channel and quench fura-2 fluorescence essentially stoichiometrically at physiological [Ca 2ϩ ] i . The rate of quenching is directly proportional to the net influx across the sarcolemma (Merritt et al., 1989) . The rate of fluorescence loss was slow in the absence of MnCl 2 . Addition of Mn 2ϩ resulted in a quench rate of 5.5%/min in cells maintained without electrical stimulation. This increased to 17%/min during electrical stimulation at 1 Hz (p Ͻ 0.01). In the presence of nifedipine (10 M) there was no activation of the quench rate by electrical stimulation, producing a quench rate similar to that observed in the absence of electrical stimulation. This indicates that the basal Mn 2ϩ quench in the absence of electrical stimulation is primarily independent of voltage-operated Ca 2ϩ channels. When the Ca 2ϩ channels were activated by exposing the cardiomyocytes to isoproterenol (1 M), there was a significant increase in the electrical stimulation-dependent component of the Mn 2ϩ quench of fura-2, which initially increased 8-fold over control (p Ͻ 0.01).
Pretreatment of myocytes with IL-2 at 200 U/ml did not elicit a significant alteration in the initial rate of Mn 2ϩ quench activated by electrical stimulation compared with control (p Ͼ 0.05) ( Table 1) .
Effect of IL-2 on Ca 2؉ -ATPase Activity of Rat Heart SR. Ca 2ϩ -ATPase activity was measured by an optical assay in crude SR extracted from control and IL-2-treated rat hearts. The specific Ca 2ϩ -ATPase inhibitor thapsigargin depressed Ca 2ϩ -ATPase activity concentration dependently in preparations from the control rat myocardium (Fig. 4A) .
In contrast, when rat hearts were perfused with IL-2 (10, 40, 200, or 800 U/ml), the activity of SR Ca 2ϩ -ATPase increased in a dose-dependent manner (Fig. 4B) .
Effect of IL-2 on Ca 2؉ -ATPase Activity as a Function of ATP. Ca 2ϩ -ATPase activity was determined as a function of ATP concentration in the SR from control and IL-2 perfused hearts. After incubating the SR with 0.1 to 4 mM ATP, the activity of Ca 2ϩ -ATPase increased dose dependently in the control group. In the SR from IL-2 perfused hearts, a dose-dependent response to ATP was also observed; but the activity of Ca 2ϩ -ATPase was considerably elevated over that in the control group (Fig. 5) .
Effect of IL-2 on Ca 2؉ -ATPase Activity as a Function of Calcium. The activity of Ca 2ϩ -ATPase activity as a function of free Ca 2ϩ concentration was determined in the SR from untreated and IL-2 (200 U/ml) perfused rat hearts. The data in Fig. 6A show that the activity of SR Ca 2ϩ -ATPase in untreated hearts increased in a dose-dependent manner, whereas the activity in IL-2 perfused hearts did not rise significantly as the free calcium concentrations increased, remaining below control values at 10, 20, and 40 M of free [Ca 2ϩ ]. 
Effect of IL-2 on Ca
2؉ -ATPase Activity of Rat Hearts Pretreated with nor-BNI. After pretreatment with the specific -opioid receptor antagonist nor-BNI (10 nM) for 10 min, IL-2 perfusion in the isolated heart failed to induce changes in the activity of SR Ca 2ϩ -ATPase. Treatment with nor-BNI (10 nM) alone did not significantly alter the activity of SR Ca 2ϩ -ATPase (Fig. 6B) . As Fig. 5 shows, after pretreatment with nor-BNI (10 nM) for 10 min, IL-2 failed to elevate the SR Ca 2ϩ -ATPase activity as a function of ATP. Similarly, the effect of IL-2 on the SR Ca 2ϩ -ATPase activity as a function of free calcium was also attenuated by pretreatment with nor-BNI (Fig. 6A) . Exposure to nor-BNI (10 nM) alone did not significantly alter the activity of SR Ca 2ϩ -ATPase as a function of ATP or free calcium (data not shown).
Effect of IL-2 on the Activity of Ca 2؉ -ATPase in Isolated SR. We also tested the effect of IL-2 on the activity of Ca 2ϩ -ATPase in isolated SR from untreated hearts. The isolated SR was incubated with IL-2 at 10, 40, 200, and 800 U/ml. IL-2 did not affect Ca 2ϩ -ATPase activity over this range of concentrations. Ca 2ϩ -ATPase activity in the isolated SR was determined as a function of ATP concentration. After incubation with 0.1 to 4 mM ATP, the activity of Ca 2ϩ -ATPase of isolated SR increased dose dependently, and there was no significant difference between the control and IL-2-treated SR vesicles (data not shown).
Effect of IL-2 on SR Ca 2؉ Uptake and SR Ca 2؉ Content. To examine the effects of IL-2 on Ca 2ϩ uptake by the SR Ca 2ϩ -ATPase, we performed Ca 2ϩ uptake measurements fluorometrically in isolated cardiac SR using fura-2. As illustrated in Fig. 7 , free calcium concentration outside of the SR declined much more slowly in the SR isolated from IL-2 perfused rat heart. The decay constant in the presence of IL-2 was approximately half that of the control. Pretreatment with nor-BNI (10 nM) for 10 min attenuated the effect of IL-2.
To confirm the results from cardiac SR Ca 2ϩ uptake, we determined the SR Ca 2ϩ content using atomic absorption spectrophotometry. As shown in Fig. 8 , the Ca 2ϩ content in cardiac SR prepared from IL-2-treated rat heart was less than that in control rat heart. Pretreatment with nor-BNI attenuated the decrease of SR Ca 2ϩ content by IL-2. Effect of IL-2 on Intracellular cAMP Levels in the Isolated Rat Heart. To determine further whether a cAMPdependent pathway was involved in the intracellular calci- Fig. 7 . Effect of IL-2 (200 U/ml) on Ca 2ϩ uptake by cardiac SR vesicles. A, cardiac SR vesicles (250 g of SR protein) prepared from a control rat were administered 1.5 M CaCl 2 . B, SR vesicles prepared from an isolated rat heart perfused with IL-2 (200 U/ml) for 10 min. C, SR vesicles prepared from an isolated rat heart pretreated with nor-BNI (10 nM) for 10 min followed by perfusion with IL-2 (200 U/ml) for 10 min. D, averaged (means Ϯ S.D.) time constants of Ca 2ϩ uptake in control, IL-2, and nor-BNI ϩ IL-2 groups (seven, eight, and eight independent measurements, respectively). ‫,ءء‬ p Ͻ 0.01 compared with control; † †, p Ͻ 0.01 compared with IL-2. jpet.aspetjournals.org um-related events induced by IL-2, we studied the effect of IL-2 on intracellular cAMP concentrations in isolated rat heart treated with IL-2 at 200U/ml. The cytosolic cAMP level in the ventricles treated with IL-2 was decreased compared with control. The reduction of cAMP by IL-2 was abolished by 10 nM nor-BNI (Fig. 9) .
Effect of IL-2 on the Activity of Sarcolemmal Ca 2؉ -ATPase. In a separate series of experiment, we measured the activity of sarcolemmal Ca 2ϩ -ATPase in the rat heart to determine whether IL-2 affects both the sarcolemmal and the SR Ca 2ϩ -ATPase activity. The hearts were perfused with IL-2 at 10, 40, 200, and 800 U/ml, and then the sarcolemma was isolated. IL-2 over this range of concentrations did not affect the activity of sarcolemmal Ca 2ϩ ATPase (IL-2 at 0, 10, 40, 200, and 800 U/ml: 2.94 Ϯ 0.12, 2.88 Ϯ 0.11, 2.83 Ϯ 0.10, 2.96 Ϯ 0.14, and 2.88 Ϯ 0.10 mol of Pi/mg protein/h, respectively).
Discussion
The findings reported here show that perfusion of the rat heart with IL-2 increased the activity of SR Ca 2ϩ -ATPase dose dependently and that this effect is mediated, at least in part, via the cardiac -opioid receptor pathway. Although treatment with IL-2 can increase the activity of SR Ca 2ϩ -ATPase as a function of ATP concentration, IL-2 acts mainly by reducing the sensitivity of SR Ca 2ϩ -ATPase to free calcium, which is also mediated via -opioid receptors; as a result, SR Ca 2ϩ uptake and SR Ca 2ϩ content are reduced. In previous studies, it was shown that IL-2 has a negative inotropic effect in isolated ventricular papillary muscle (Finkel et al., 1992) and cardiomyocytes, accompanied by a reduction of intracellular calcium transients (Cao et al., 2002) . In the present study, IL-2 decreased the electrically stimulated calcium transient as well as caffeine-induced calcium release from SR, which indicates that IL-2 affects the intracellular calcium handling system. The decreased calcium release from SR induced by caffeine may be caused by inhibition of SR Ca 2ϩ -ATPase, which results in reduced reuptake and refilling of calcium in SR. Reduction of extracellular calcium entry could result in a decrease of cytoplasmic free calcium level, which would then reduce caffeine-induced calcium release. But, we found that the activity of sarcolemmal L-type calcium channels, as determined by whole cell patch-clamp and Mn 2ϩ quench experiments, was not altered by IL-2 treatment. So, it seems that the reduced intracellular calcium transient induced by IL-2 is a consequence of decreased releasable calcium in cardiomyocyte SR, mainly as a result of decreased reuptake of calcium into the SR. In the present study, it was demonstrated that Ca 2ϩ uptake and Ca 2ϩ content of the SR prepared from IL-2-treated rat heart were markedly decreased, which suggests that the SR Ca 2ϩ uptake mechanism is a likely target of IL-2 in cardiac muscle. This result is consistent with the observation of delayed decay of the electrically stimulated [Ca 2ϩ ] i calcium transient by IL-2. In the present study, we found that IL-2 increased the activity of SR Ca 2ϩ -ATPase dose dependently, and the increased activity was a function of ATP concentration. These results seem paradoxical compared with the observation that IL-2 decreased SR Ca 2ϩ uptake. In another series of experiments, we found that IL-2 decreased the sensitivity of SR Ca 2ϩ -ATPase to calcium, which may reduce the efficacy of SR Ca 2ϩ -ATPase, thus lowering the calcium transport rate and the loading/refilling of the SR with calcium. Therefore, the summation of two opposing effects induced by IL-2, i.e., increased SR Ca 2ϩ -ATPase activity and decreased responsiveness of SR Ca 2ϩ -ATPase to calcium, reduces the calcium reuptake into SR. That the latter effect is probably dominant in the cardiac action of IL-2 is supported by the experiments on SR Ca 2ϩ uptake and SR Ca 2ϩ content. An interesting matter for discussion arises when considering sites at which IL-2 acts in cardiomyocytes. Incubation of IL-2 with isolated SR from untreated hearts had no effect on the SR Ca 2ϩ -ATPase activity, whereas perfusion with IL-2 in isolated hearts increased the SR Ca 2ϩ -ATPase activity, suggesting that the cell membrane may participate in the effect of IL-2 on SR Ca 2ϩ -ATPase activity. Furthermore, we found no effect of IL-2 on the sarcolemmal Ca 2ϩ -ATPase, providing evidence that this is not a target in the cardiac effect of IL-2.
Further support for the above-mentioned findings are provided by the results of pretreatment with opioid receptor antagonists. Rat hearts perfused with a single dose of nor-BNI, a selective -opioid receptor antagonist, showed a significant reduction of the activation of SR Ca 2ϩ -ATPase as well as the responsiveness to calcium of IL-2, which indicates the participation of sarcolemmal opioid receptors. The complex interactions between the classical cytokines and opioids are manifest within the nervous and immune systems. For Interleukin-2 and Calcium Handling in Rat Heart 579 at ASPET Journals on June 2, 2017 jpet.aspetjournals.org example, in the rat central nervous system, antiopioid sera inhibit the central analgesic effect of IL-2 (Jiang et al., 2000) . Furthermore, in a previous study, we found that cardiac -opioid receptors mediate the effect of IL-2 on cell contraction and intracellular calcium transients (Cao et al., 2002) . The present study is the first report to establish a pharmacological connection between SR Ca 2ϩ -ATPase activity and cardiac sarcolemmal -opioid receptors.
Sarcoplasmic reticulum is the major intracellular Ca 2ϩ store. Most of the Ca 2ϩ that activates the contractile process is released from the SR store of calcium that is removed from the cytosol during diastole. SR Ca 2ϩ uptake is mediated by the SR Ca 2ϩ -ATPase (Lompre et al., 1994; Misquitta et al., 1999) , whose activity is regulated by the small, 52 amino acid protein phospholamban, of which no subtypes are known (Simmerman and Jones, 1998) . In its basal unphosphorylated state, phospholamban inhibits the SR Ca 2ϩ -ATPase by decreasing its affinity for Ca 2ϩ (James et al., 1989; Voss et al., 1994; Hasenfuss et al., 1997) , whereas in its phosphorylated state, it enhances SR Ca 2ϩ -ATPase activity (James et al., 1989) via an increase in its affinity for calcium without changing the maximum reaction rate of the enzyme (Luo et al., 1994; Odermatt et al., 1996) . Phosphorylation of myocardial phospholamban is catalyzed by several enzymes, including calcium/calmodulin-dependent protein kinase and cAMP-dependent protein kinase A, with distinct sites of phosphorylation by each kinase (Lompre et al., 1994; Lompre, 1998) . In the present study, we found that treatment with IL-2 at 200U/ml decreased the intracellular cAMP concentrations in the isolated rat heart, which suggests that cAMP is a target component of IL-2 in the heart. It is also known that cardiac -opioid receptor stimulation inhibits adenylyl cyclase via G i/o proteins, leading to a decreased intracellular cAMP level (Zhang and Wong, 1998) . Combined with the result in the present study that IL-2 decreased the sensitivity of SR Ca 2ϩ -ATPase to free calcium, this indicates that the activation of -opioid receptor by IL-2 results in a decreased intracellular cAMP level, which may be responsible for reduced sensitivity of SR Ca 2ϩ -ATPase to calcium by affecting the degree of cAMP-dependent phosphorylation of phospholamban.
